The 1 October 2014 issue of the Schedule of Pharmaceutical Benefits is now available.   The schedule contains a number of new and revised listings:

• Eribulin mesylate (Halaven) – new listing
• Glucose indicator (Easy Mate II) – new formulation
• Oestradiol and oestradiol with dydrogesterone (Femoston 1/10) – new strength
• Oestradiol and oestradiol with dydrogesterone (Femoston-Conti) – new strength
• Strontium ranelate (Protelos) – Restriction change
• Varenicline tartrate (Champix) – Restriction change

For more details, go to: http://www.pbs.gov.au/browse/changes